Extracorporeal Shock Waves versus Botulinum Toxin Type A in the Treatment of Post-Stroke Upper Limb Spasticity – A Randomized, Noninferiority Trial

To investigate whether extracorporeal shock wave therapy (ESWT) is noninferior to botulinum toxin type A (BoNT-A) for the treatment of post-stroke upper limb spasticity.
Source: Archives of Physical Medicine and Rehabilitation - Category: Rehabilitation Authors: Source Type: research
More News: Botox | Rehabilitation | Stroke